Auranofin Capsule
Product Images NDC 85437-093

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Auranofin (NDC 85437-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Coral Way Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Label3)

This is a medication label for Auranofin capsules, each containing 3mg of the active ingredient. The usual adult dosage is either 3mg twice daily or 6mg once daily, as directed by the prescribing information. It is important to store the capsules between 15°C-30°C and dispense them in a tight, light-resistant container. Safety closures should be used when dispensing unless instructed otherwise by the physician. The drug should be kept out of reach of children. This medication is distributed by CoralWay Pharma, LLC based in San Antonio, TX.*

FDA Label Image

Chemical Structure (Rid01 0003 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.